Compounds > sq-11725
Page last updated: 2024-08-23

sq-11725 and Angioma

sq-11725 has been researched along with Angioma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Cushing, SL; Pope, E; Propst, EJ; Wolter, JK; Wolter, NE; Yang, W1
Bautista-Paloma, FJ; Cotrina-Luque, J; Del Vayo-Benito, CA; Flores-Moreno, S; Villalba-Moreno, AM1
Chakkittakandiyil, A; Lara-Corrales, I; Maki, E; Pope, E; Weinstein, M1

Other Studies

3 other study(ies) available for sq-11725 and Angioma

ArticleYear
Propranolol versus nadolol for treatment of pediatric subglottic hemangioma.
    International journal of pediatric otorhinolaryngology, 2021, Volume: 144

    Topics: Adrenergic beta-Antagonists; Child; Female; Hemangioma; Humans; Infant; Male; Nadolol; Propranolol; Retrospective Studies; Treatment Outcome

2021
Nadolol for the treatment of infantile hemangioma.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2015, Jan-01, Volume: 72, Issue:1

    Topics: Adrenergic beta-Antagonists; Blood Pressure; Child, Preschool; Female; Heart Rate; Hemangioma; Humans; Infant; Nadolol; Propranolol; Skin Neoplasms; Treatment Outcome

2015
Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol.
    The British journal of dermatology, 2013, Volume: 168, Issue:1

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Drug Administration Schedule; Feasibility Studies; Female; Head and Neck Neoplasms; Hemangioma; Humans; Infant; Male; Nadolol; Propranolol; Treatment Outcome

2013